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Abstract
The b-hexosaminidase inhibitor and structural analog of the putative oxazolium reaction intermediate of lytic transglycosylases,
N-acetylglucosamine thiazoline (NAG–thiazoline), was synthesized in 46% overall yield and tested as an inhibitor of Escherichia coli
growth. NAG–thiazoline, at concentrations up to 1 mg/ml, was not found to aﬀect the viability of E. coli DH5a. However, the
compound did induce morphological changes to the cells. Growth of cells in the presence of NAG–thiazoline caused an apparent
inhibition of the biosynthesis of the cylindrical regions of the cells such that they became much shorter in length. The surface of these
shorter cells was found to be much less hydrophobic compared to untreated cells as determined by the bacterial adhesion to hydrocarbon (BATH) assay. In addition, the co-administration of NAG–thiazoline with 1.7  MIC concentrations of ampicillin
prevented cell lysis suggesting that the compound inhibited autolytic enzymes, in particular the lytic transglycosylases.
Ó 2004 Federation of European Microbiological Societies. Published by Elsevier B.V. All rights reserved.
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1. Introduction
The generally accepted model for the biosynthesis of
peptidoglycan in Escherichia coli invokes enzyme complexes comprised of both transferases, a collection of
penicillin-binding proteins (PBPs), and the lytic transglycosylases (LTs) (recently reviewed by Young [1]). The
high-molecular weight PBPs catalyse the incorporation
of newly synthesized and translocated peptidoglycan
precursor molecule, Lipid II, into the existing sacculus
at sites made available through the action of the LTs.

Abbreviations: GlcNAc, N-acetylglucosamine; MurNAc, N-acetylmuramic acid; NAG–thiazoline, N-acetylglucosamine-thiazoline; LT,
lytic transglycosylase; PBP, penicillin-binding protein; SEM, scanning
electron microscopy.
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Inhibition of the transglycosylase or transpeptidase activities of the PBPs by moenomycin and the b-lactam
antibiotics, respectively, leads to autolysis through the
continued action of the LTs (reviewed in [2]). In addition, mutant strains deﬁcient in either of the two classes
of enzymes are characterized by signiﬁcantly altered cell
morphologies [1,3].
While much eﬀort has been made to understand the
function and mechanism of action of the PBPs with the
aim to extend their usefulness as a target for antibacterial therapy, the LTs have attracted considerably less
attention [4]. LTs function to cleave the same bond in
peptidoglycan as the lysozymes, speciﬁcally the b(1 ! 4)-glycosidic bond between the MurNAc and GlcNAc residues [5,6]. However, the LTs are catalytically
distinct from the hydrolytic lysozymes because they are
not hydrolases but cleave peptidoglycan with the concomitant formation of 1,6-anhydro-MurNAc residues
(Fig. 1) [5].
LTs appear to be ubiquitous in the eubacteria that
produce peptidoglycan (viz., all but the cell wall-less
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Fig. 1. Proposed reaction pathway of lytic transglycosylases (LT) and structure of NAG–thiazoline, an analogue of the oxazolium intermediate. R
denotes the stem peptide of muramoyl residues involved in cross-linking of the glycan strands of peptidoglycan which are comprised of alternating
GlcNAc and MurNAc residues.

mycoplasmas), and even in some lytic bacteriophages
[7]. Given the apparent importance of these enzymes to
the growth of the bacteria, the search for inhibitors of
the LTs may prove to be valuable for the development
of a new class of antibiotics with broad speciﬁcity. Based
on both X-ray crystallographic and inhibition studies
with bulgecin [8–10], it has been suggested that the LTs
use substrate-assisted catalysis which proceeds through
the formation of an oxazolium intermediate (Fig. 1)
involving the muramyl residue at the site of cleavage in
peptidoglycan. Recent investigations in our laboratory
[11] have shown that puriﬁed LTs are inhibited by the bhexosaminidase inhibitor and structural analog of the
putative oxazolium intermediate, N -acetylglucosamine
thiazoline (NAG–thiazoline) [12,13] (Fig. 1). In this
study, we show that NAG–thiazoline causes changes to
both morphology and cell surface hydrophobicity in
growing E. coli cells, while also inhibiting b-lactam-induced autolysis.

tate was chromatographed on silica gel with ethyl
acetate/hexane (7:1) as the solvent to give 0.42 g (46%)
of puriﬁed peracetate.
A portion of the thiazoline triacetate (0.42 g) was
treated with 0.2 M methanolic sodium methoxide (10
ml) with stirring for 10 min. After de-ionization with
Bio-Rad 50W-X4 (Hþ form; Bio-Rad Laboratories)
cation-exchange resin, the reaction mixture was ﬁltered
and the ﬁltrate was concentrated to give 0.27 g NAG–
thiazoline as a hygroscopic brownish solid. Purity and
identity to the known NAG–thiazoline [13] was conﬁrmed by TLC and NMR analysis. Rf 0.21 (2:1:1:1 ethyl
acetate/isopropanol/H2 O/acetic acid); 1 H NMR (400
MHz, CD3 OD) d 6.37 (d, 1H, J ¼ 7:0 Hz, H-1), 5.60 (d,
0.1H, J ¼ 4:7 Hz, residual GlcNAc H-1) 4.30 (m, 1H,
H-2), 4.19 (t, 1H, J ¼ 4:0 Hz, H-3), 3.78 (dd,1H,
J ¼ 2:6, 12 Hz, H-61 ), 3.65 (dd, 1H, J ¼ 6:1, 12 Hz, H6), 3.62 (ddd, 1H, J ¼ 1:0, 3.8, 9.1 Hz, H-4), 3.28 (m,
1H, H-5), 2.22 (d, 3H, J ¼ 1:6 Hz, Thiazoline CH3 ). 13 C
NMR (100 MHz, CD3 OD) d 170.0 (SC@N), 90.80,
80.65, 76.40, 74.23, 71.43, 63.45, 24.25.

2. Materials and methods
2.2. Growth studies
2.1. Synthesis of NAG–thiazoline
NAG–Thiazoline was prepared in 46% overall yield
from peracetylated GlcNAc by treatment with Lawesson’s reagent according to the procedure of Knapp et al.
[13] with modiﬁcations. Thus, a solution of 1.03 g (2.66
mmol) of 2-acetamido-2-deoxy-1,3,4,6-tetra-O-acetyl-bD -glucopyranose (Toronto Research Chemicals, Toronto, Ont.) in 10 ml of dry toluene was treated with
0.68 g (1.68 mmol) of Lawesson’s reagent (Sigma–Aldrich, St. Loius, MO), and the reaction mixture was
heated to 60 °C for 1.5 h. The reaction mixture was then
cooled to room temperature, washed with H2 O, dried
over anhydrous Na2 SO4 , and concentrated. The resulting yellow syrup containing the crude thiazoline triace-

Growth of E. coli DH5a (Clonetech) cultures in the
presence and absence of NAG–thiazoline was examined
by culturing one colony in Luria–Bertani (LB) broth
(1% tryptone peptone, 1% NaCl, 0.5% yeast extract) at
37 °C with shaking. After 16 h, a 1/50 dilution of the
culture was performed in triplicate into fresh LB broth
containing NAG–thiazoline and growth was monitored
turbidometrically (OD600 ). Identical dilutions of the
starter culture were inoculated into fresh LB broth alone
to serve as controls.
In other experiments to examine the eﬀect of NAG–
thiazoline on penicillin-induced autolysis, cultures of E.
coli DH5a were grown in LB broth at 37 °C to a cell
density of OD600 of 0.18 (early exponential phase) and
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divided into three aliquots. Each aliquot was then supplemented with either nothing (to serve as controls), 5
lg/ml (1.7  MIC) ampicillin, or 5 lg/ml ampicillin and
300 lg/ml NAG–thiazoline. Subsequent growth at 37 °C
was monitored turbidometrically for 5 h while samples were withdrawn periodically for microscopic
examination.
2.3. Morphological eﬀect of NAG–thiazoline on E. coli
Phase contrast microscopy of unstained wet mounts
of cells was conducted using Nomarski optics on a Leica
microscope with diﬀerential interference contrast. Images were captured and then processed with Adobe
Photoshop software.
For scanning electron microscopy, cells were harvested from 1 ml samples of cultures by centrifugation at
8000g for 10 min at 4 °C. The bacterial cell pellet was
washed in phosphate buﬀered saline to remove any residual broth. The pellet was then suspended in 70 mM
Sorensen’s phosphate, pH 6.8, placed on a 0.2 lm
polycarbonate membrane ﬁlter (Poetics Corp. Livermore, CA), and ﬁxed with 2% gluteraldehyde in phosphate-buﬀered saline for 1 h and post-ﬁxed with OsO4 .
The samples were then rinsed in several changes of
buﬀer, dehydrated through a series of ethanol washes,
critical point dried (Ladd Industries) using carbon dioxide, and sputter coated with 20 nm of gold/palladium
in a Hummer VII sputter coater (Anatech Corp. Alexandria, VA). To visualize the organisms, the ﬁlters were
scanned using a Hitachi S-570 SEM (Tokyo, Japan),
and images were collected directly from the SEM using
Quartz PCI software (Quartz Imaging Corp. Vancouver, BC).
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Rosenberg et al. [15]. Cells grown to late exponential
phase in LB broth containing 0, 100, 300, or 600 lg/ml
of NAG–thiazoline were harvested by centrifugation
and washed with 3 ml of 150 mM phosphate buﬀer, pH
7.1 containing 30 mM urea and 0.8 mM MgSO4 . Triplicate samples of the washed cells were resuspended in
the same buﬀer to an OD400 of 1.0, transferred to glass
test tubes, and treated with 0.1 ml hexadecane. Following incubation for 15 min at 37 °C with shaking, the
samples were vortexed for 2 min and the phases were
allowed to separate for 10 min. The OD400 of each of the
aqueous phases was measured and expressed as a percentage of the diﬀerence between the adhesion to the
glass and adhesion to hexadecane.

3. Results and discussion
3.1. Growth inhibition studies
The addition of up to 600 lg/ml NAG–thiazoline did
not aﬀect E. coli cultures grown in LB broth as
compared to cultures supplemented with equal concentrations of GlcNAc, the parent compound of NAG–
thiazoline (data not shown). To further examine for any
inhibitory eﬀect of NAG–thiazoline on cell growth, determination of its minimum inhibitory concentration
was attempted. Thus, doubling dilutions of the compound were added to LB broth and growth was monitored turbidometrically following inoculation and
incubation at 37 °C for 8 h. As with the growth curve
experiments, all cultures were found to be viable and
NAG–thiazoline was not found to inhibit growth at
concentrations as high as 1 mg/ml.

2.4. Aﬀect of NAG–thiazoline on LPS proﬁle of E. coli

3.2. Morphological eﬀect of NAG–thiazoline on E. coli

Cultures of E. coli DH5a grown for 6 h (late
exponential phase) in LB containing 0 or 600 lg/ml
NAG–thiazoline (each in triplicate) were harvested by
centrifugation (6000g, 10 min, 4 °C) and the cells were
resuspended in 100 ll of NuPAGEÒ (Invitrogen Life
Technologies Inc.) sample buﬀer for analysis of their
LPS proﬁles [14]. After incubation at 100 °C for 10 min,
50 lg of Proteinase K was added and incubated at 60 °C
for 1h. Samples were then boiled at 100 °C for 10 min
and diluted 1/10 before loading onto a NuPAGEÒ 4–
12% gradient electrophoresis gel. Samples were subjected to electrophoresis for 80 min at 120 V and the
LPS was detected by silver staining.

Bulgecin (a natural product comprised of a 4-O-sulfonyl-GlcNAc residue linked with a 4-hydroxy-5-(hydroxymethyl)-L -proline), in combination with sub-lethal
concentrations of b-lactam antibiotics, has been shown
to cause prominent bulges in the middle of elongated E.
coli cells without being inhibitory to cell growth [9].
Subsequent in vitro studies indicated that the compound
inhibits only the family 1 E. coli lytic transglycosylase,
Slt70 at low concentrations [8,9] suggesting a speciﬁc
role for this enzyme in the maintenance of cell shape and
peptidoglycan metabolism. Given that this selective lytic
transglycosylase inhibitor does not inhibit growth but
rather aﬀects the cell morphology of E. coli, cells grown
in the presence and absence of NAG–thiazoline were
prepared for examination by phase contrast microscopy.
Cells grown at 37 °C in LB broth for 3 h in the presence
of 600 lg/ml NAG–thiazoline displayed an unusual
rounded up or ‘‘stubby’’ morphology (Fig. 2). This
change occurred in all cells. In contrast, cells treated

2.5. Cell-surface hydrophobicity assay
Surface hydrophobicity of cells grown in the presence
and absence of NAG–thiazoline was assessed using the
bacterial adhesion to hydrocarbon (BATH) assay of

346

C.W. Reid et al. / FEMS Microbiology Letters 234 (2004) 343–348

ments involved the examination of E. coli cells treated
with 300 lg/ml NAG–thiazoline which showed only a
15% decrease in cell length compared to the control
samples incubated in the absence of the compound(data
not shown). However, it became apparent that the SEM
images did not represent the entire cell population because the absolute total of treated cells observed in the
SEM ﬁelds was considerably lower compared to that
from control cultures. Thus, only a sub-population of
the treated cells were ﬁxed to the polycarbonate membranes negating the opportunity to observe and measure
the smaller ones seen by phase microscopy.
3.3. Analysis of cell surface properties

Fig. 2. Phase contrast micrographs of E. coli DH5a cells grown in LB
broth at 37 °C and the (A) absence and (B) presence of 600 lg/ml
NAG–thiazoline. Bar denotes 5 lm.

with equivalent concentrations of GlcNAc showed no
such alteration in morphology. It should be noted that,
unlike the situation with bulgecin, the observed change
in cell morphology caused by NAG–thiazoline did not
require the co-administration of sub-lethal quantities of
b-lactams suggesting that, in this case, more than one
type of LT may have been aﬀected by exposure to
NAG–thiazoline. Indeed, the non-lethal aﬀect of NAG–
thiazoline on cell morphology is more analogous to the
observations made with mutant strains of E. coli in
which the genes of all six known membrane-bound lytic
transglycosylases have been disrupted [3]. These deletion
mutants showed growth in chains and were slightly
coccoid in shape (viz., a reduction in cylindrical cell
shape). However, while this interpretation is consistent
with the observations, it is also conceivable that NAG–
thiazoline may inhibit a diﬀerent class of enzyme associated with cell morphology.
Scanning electron microscopy (SEM) was used in an
eﬀort to provide both further details and a statistical
analysis of the morphological changes to E. coli resulting from exposure to NAG–thiazoline. Initial experi-

The ﬁnding that the shorter, treated E. coli cells did
not adhere to SEM grids suggested the surface properties of these cells was altered, likely as an indirect result
of the morphological changes. A preliminary investigation of this possibility was conducted by analysing both
the LPS proﬁles and cell surface hydrophobicities of the
cells. The LPS proﬁles of cells grown in the presence of
NAG–thiazoline, as judged by gel electrophoresis, were
not signiﬁcantly diﬀerent to control cells (data not
shown). This result was not unexpected given that E. coli
DH5a is a rough strain thus producing LPS molecules
comprised of lipid A, core oligosaccharide, and no more
than one O-chain subunit. However, the overall hydrophobicity of the cell surface was greatly inﬂuenced by
growth in the presence of NAG–thiazoline. As indicated
in Table 1, the surface of treated cells was clearly more
hydrophilic in nature as very few cells partitioned into
the organic solvent compared to those from control
cultures. Moreover, this alteration in cell surface
hydrophobicity appeared to be dependant on NAG–
thiazoline concentration. Similar alterations in cell surface hydrophobicity have been observed with diﬀerent
pathogenic bacteria following antibiotic treatments and
can result in modiﬁed adhesion propensity and thereby
their pathogenicity (e.g., [16] and references therein).
3.4. Inhibition of penicillin-induced lysis by NAG–thiazoline
Changes to bacterial cell morphology have to involve
alterations, either directly or indirectly, to the metabo-

Table 1
Cell surface hydrophobicities of E. coli DH5a
Growth conditions

BATH (%)a

Control
+100 lg/ml NAG thiazoline
+300 lg/ml NAG thiazoline
+600 lg/ml NAG thiazoline

31.1  2.76
22.6  3.57
9.64  0.772
2.86  0.316

a

Mean  SD (n ¼ 3).
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lism of the rigid cell wall polymer peptidoglycan. NAG–
thiazoline has been used previously to investigate the
reaction mechanism of a bacterial b-hexosaminidase
[12,13,17]. NAG–thiazoline–lipid II hybrids have also
been synthesized as potential inhibitors of transglycosylases involved in peptidoglycan biosynthesis [18]. Recent
studies in our laboratory have shown NAG–thiazoline to
be an inhibitor of the lytic transglycosylases [11]. Thus,
the morphological changes accompanying the treatment
of cells with NAG–thiazoline observed in this study may
have resulted from the inhibition of one or more autolytic enzymes, including the lytic transglycosylases. This
view was supported by observations that the co-administration of this compound with ampicillin prevented the
cell autolysis that normally accompanies exposure to blactam antibiotics. As shown in Fig. 3, the addition of
1.7  MIC (viz. 5 lg/ml) of ampicillin to growing cultures of E. coli resulted in both the cessation of growth
and a time-dependent loss in turbidity consistent with the
onset of autolysis. This lysis was conﬁrmed by microscopic examination of the cultures. Inclusion of 300 lg/
ml NAG–thiazoline together with the b-lactam did not
prevent the antibiotic-induced cessation of growth, but
in contrast to the control cultures, these cells did not
undergo autolysis. Moreover, the extremely elongated
cell morphology that results from treatment of E. coli
with ampicillin prior to their autolysis was not observed
with cells co-treated with NAG–thiazoline (data not
shown). Given these observations, together with the in
vitro studies made with puriﬁed lytic transglycosylase
[11], it is tempting to speculate that NAG–thiazoline
inhibits the lytic transglycosylases that comprise the
complexes responsible for the biosynthesis of peptidoglycan in the cylindrical regions of the sacculus. Clearly,
however, more detailed studies will be required to
support this view.
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3.5. Concluding remarks
By virtue of its unique chemical structure in nature
and its importance to bacterial cell viability, the metabolism of peptidoglycan has been exploited as a target for
antibacterial drug development (recently reviewed by
Koch [19]). Unfortunately, some of the important antibiotics developed are quickly becoming irrelevant for
clinical use as drug resistance levels increase in both
human and animal pathogens. For example, the prevalence of b-lactamases among a variety of important
pathogens has seriously compromised the general therapeutic use of the b-lactams (monobactams, penicillins,
cephalosporins), compounds that are functional analogs
of the stem peptide portion of the peptidoglycan-repeating unit. Using a diﬀerent mode of resistance, vancomycin-resistance in enterococci (VRE) develops when
alterations arise in the stem peptides of their peptidoglycan resulting in a decreased aﬃnity for the antibiotic
[20]. Despite these alarming trends, however, the peptidoglycan sacculus still contains other potential targets
for drug development [21], including the lytic transglycosylases. The apparent ubiquity of these enzymes
amongst the bacteria [7] further supports their usefulness
as an antibacterial target. The ability of NAG–thiazoline
to cause changes to the hydrophobicity of the E. coli cell
surface, a factor associated with adherence of pathogens
to host cells, together with the inhibition of peptidoglycan biosynthetic complexes responsible for cell morphology and autolysis demonstrated in this study
provides further impetus to continue investigating the
potential of the lytic transglycosylases as an alternative
target for the development of a new class of antibiotics.
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Fig. 3. Inhibition of ampicillin-induced lysis by NAG–thiazoline.
Cultures of E. coli DH5a were grown in LB broth at 37 °C to a cell
density of OD600 of 0.18 (early exponential phase), divided into three
aliquots, and then supplemented with (d) nothing (control), (j) 5 lg/
ml (1.7  MIC) ampicillin, or (N) 5 lg/ml ampicillin and 300 lg/ml
NAG–thiazoline. The error bars denote standard deviation (n ¼ 3).
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